| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥2086.4B | ¥1949.7B | +7.0% |
| Operating Income | ¥215.9B | ¥230.8B | -6.4% |
| Ordinary Income | ¥216.2B | ¥222.0B | -2.6% |
| Net Income | ¥95.5B | ¥144.3B | -33.9% |
| ROE | 8.6% | 13.6% | - |
FY2026 Q3 cumulative results for this consolidated period show Revenue of 208.6B yen (YoY +7.0%), Operating Income of 21.6B yen (YoY -6.4%), Ordinary Income of 21.6B yen (YoY -2.6%), and Net Income of 9.5B yen (YoY -33.9%). While the company achieved top-line growth driven by expansion in Japan and select overseas markets, bottom-line profitability was significantly impacted by non-recurring impairment charges totaling 4.9B yen, elevated corporate overhead expenses, and a high effective tax rate of approximately 41.1%. The divergence between revenue expansion and profit contraction reflects both operational cost pressures and one-time asset write-downs, particularly goodwill impairment at TOMY International Inc. in the Americas segment.
Revenue increased 13.7B yen YoY to 208.6B yen, representing 7.0% growth. Japan segment external sales reached 163.0B yen, constituting approximately 78% of consolidated revenue and demonstrating core market strength. Asia segment sales grew to 14.2B yen from prior year's 11.6B yen, while Americas segment sales of 23.0B yen showed slight decline from 24.8B yen. Europe and Oceania maintained relatively stable contributions at 6.2B yen and 2.2B yen respectively. The revenue growth occurred alongside a 24.9% increase in inventory to 24.9B yen and a substantial 56.1% increase in accounts receivable to 46.1B yen, suggesting extended payment terms or collection timing factors supporting sales expansion. Operating income decreased 1.5B yen to 21.6B yen despite revenue growth, reflecting operating margin compression from 11.8% to 10.4%. Segment-level operating profit totaled 26.7B yen before corporate expense allocations, with corporate overhead increasing to 4.8B yen from prior period's 3.8B yen, representing a 27.9% increase in unallocated general administrative expenses that exceeded revenue growth rates. The gap between operating income and ordinary income remained minimal at 0.3B yen, indicating limited non-operating factors. However, net income contracted sharply by 4.9B yen to 9.5B yen due to extraordinary losses of 5.4B yen, primarily comprising 4.9B yen in impairment losses recorded in the Americas segment related to goodwill and fixed assets at TOMY International Inc., along with smaller impairments in Japan. The effective tax rate of 41.1% on pre-tax income of 16.2B yen also contributed to net income suppression. This represents a revenue up, profit down pattern driven by operational cost escalation, non-recurring asset write-downs, and elevated tax burden that more than offset top-line momentum.
Japan segment delivered 175.6B yen in total revenue including inter-segment transactions and operating income of 24.5B yen, maintaining its position as the core business with approximately 92% of total segment profit contribution and 14.0% operating margin. Americas segment generated 23.0B yen in revenue with operating income improving to 0.5B yen from prior year's marginal 0.03B yen, though this recovery was overshadowed by the 4.9B yen impairment charge that reduced segment asset values. Asia segment contributed 52.4B yen in revenue with 1.8B yen operating profit, down from prior period's 2.3B yen, representing a margin decline to 3.5% from 4.2% YoY. Europe segment recorded 6.2B yen revenue with operating loss of 0.2B yen, slightly improved from prior year's 0.2B yen loss but remaining unprofitable. Oceania segment maintained modest profitability with 2.2B yen revenue and 0.1B yen operating income. The segment profit differential is substantial, with Japan operating margin of 14.0% significantly exceeding other regions, while Europe continues to drag on consolidated profitability. Inter-segment adjustments reduced total segment profit by 0.3B yen, reflecting intra-group transaction eliminations and transfer pricing effects.
[Profitability] ROE of 8.6% reflects the impact of compressed net profit margin on equity returns. Net profit margin of 4.6% decreased substantially from prior period as extraordinary losses and high tax burden reduced earnings conversion. Operating margin of 10.4% declined 1.4 percentage points from 11.8% YoY, indicating operating leverage deterioration despite revenue growth. [Cash Quality] Cash and deposits of 46.5B yen provide 8.1x coverage of short-term debt, though detailed cash flow statement data is not available for this quarterly period. Working capital of 71.0B yen reflects liquidity strength but includes concerning components of elevated receivables and inventory. [Investment Efficiency] Asset turnover of 1.18x substantially exceeds manufacturing industry median of 0.58x, indicating relatively efficient asset utilization despite inventory and receivables expansion. Inventory turnover of 74 days compares favorably to industry median of 109 days, though increased 18% YoY from lower base. Receivables turnover of 81 days approaches industry median of 83 days but represents deterioration from tighter collection in prior periods. [Financial Health] Equity ratio of 62.9% aligns closely with manufacturing industry median of 63.8%, maintaining strong capital adequacy. Current ratio of 223.7% significantly exceeds industry median of 283%, providing substantial short-term liquidity buffer. Financial leverage of 1.59x approximates industry median of 1.53x, reflecting moderate balance sheet gearing. Interest-bearing debt of only 0.7B yen represents minimal financial risk with debt-to-equity ratio of 0.6%, well below typical manufacturing sector leverage.
Cash and deposits increased 8.7B yen YoY to 46.5B yen, reflecting operating profit generation partially offset by working capital expansion. The substantial accounts receivable increase of 16.6B yen absorbed significant cash resources, suggesting extended customer credit terms or collection timing effects that supported sales growth but constrained cash conversion. Inventory expansion of 4.9B yen further consumed operating cash as the company built stock positions, potentially for anticipated demand or longer supply chain lead times. Accounts payable increased 5.7B yen to 20.5B yen, indicating supplier credit utilization that partially mitigated working capital cash consumption. The net working capital increase of approximately 16B yen represents a significant cash use that tempered the cash-generative impact of operating profitability. Goodwill decreased 6.0B yen to 5.1B yen due to the Americas segment impairment charge, representing a non-cash write-down that does not affect liquidity but signals prior acquisition value deterioration. Total assets expanded 10.7B yen to 176.4B yen while equity increased 4.5B yen to 110.9B yen, with the difference reflecting liability expansion including the increased payables. Cash coverage of short-term liabilities at 8.1x indicates robust liquidity position despite working capital headwinds. The balance sheet changes suggest cash generation from operations was absorbed by aggressive working capital deployment to support sales expansion, with receivables growth particularly notable as a liquidity constraint requiring management attention.
Ordinary income of 21.6B yen versus operating income of 21.6B yen shows minimal non-operating net contribution of approximately 0.3B yen. Non-operating income composition includes financial income and foreign exchange effects that had limited impact on consolidated results, with non-operating income representing less than 1% of revenue. The primary earnings quality concern stems from extraordinary items, with special losses of 5.4B yen representing 25% of operating income and comprising primarily the 4.9B yen impairment charge recognized in the Americas segment for goodwill and fixed assets at TOMY International Inc., as detailed in segment notes. This non-recurring impairment reduced net income by approximately 51% of what would have been earned absent the write-down. The effective tax rate of 41.1% applied to pre-tax income of 16.2B yen appears elevated relative to standard Japanese corporate rates, suggesting potential tax adjustments or deferred tax impacts that compressed after-tax earnings beyond the impairment effect. Interest expense of 0.4B yen on minimal debt of 0.7B yen indicates moderate financial costs. The substantial gap between operating income of 21.6B yen and net income of 9.5B yen reflects both the extraordinary loss impact and tax burden, with these factors reducing earnings conversion to 44% compared to a more typical 60-65% range. The accounts receivable expansion of 56% significantly exceeding revenue growth of 7% raises accruals concerns about revenue recognition timing versus cash collection, potentially indicating aggressive revenue recognition practices or customer credit accommodation that inflates reported sales relative to cash realization. Without detailed operating cash flow disclosure, definitive assessment is limited, but the working capital trends suggest earnings quality bears monitoring for sustainability of reported revenue growth.
Full-year guidance projects Revenue of 260.0B yen, Operating Income of 23.5B yen, Ordinary Income of 23.3B yen, and Net Income of 10.0B yen with annual dividend of 32 yen per share. Q3 cumulative progress rates are Revenue 80.2%, Operating Income 91.9%, Ordinary Income 92.8%, and Net Income 95.5% against full-year targets. Operating income progress of 91.9% substantially exceeds the standard 75% benchmark for Q3, indicating ahead-of-schedule profit realization that suggests potential for full-year upside or alternatively reflects seasonality concentration in first three quarters with weaker Q4 anticipated. Net income progress of 95.5% implies only 0.5B yen additional net income expected in Q4, which appears conservative given the Q3 cumulative result already approaches the full-year target. This near-complete achievement of net income guidance reflects the impact of the 4.9B yen impairment charge being absorbed within the annual forecast, suggesting management anticipated or accommodated the write-down in their projections. Revenue progress of 80.2% implies Q4 revenue of approximately 51.4B yen, representing 19.8% of annual total, which appears reasonable for typical quarterly distribution patterns. The guidance implies YoY changes of Revenue +3.9%, Operating Income -5.5%, and Ordinary Income -3.1% for the full fiscal year, indicating expectations for modest top-line growth with profit compression from elevated costs and the impairment impact. No revision to full-year guidance was disclosed despite Q3 results substantially achieving net income targets, suggesting management maintains the original forecast pending Q4 outcomes.
Annual dividend guidance of 32 yen per share at full-year net income target of 10.0B yen implies a payout ratio of approximately 28% based on forecasted EPS of 112.37 yen. However, against Q3 cumulative net income of 9.5B yen already approaching the full-year target, the dividend commitment represents a higher effective payout. Quarterly disclosure indicates interim dividend of 28 yen and projected year-end dividend of 36 yen for total annual dividend of 64 yen per share, which differs from the full-year guidance of 32 yen and suggests potential data reconciliation issues or reflects different reporting bases. Using the 64 yen total indicated in quarterly data against net income of 9.5B yen yields an approximate payout ratio of 62.8%, which exceeds typical sustainable levels absent strong cash flow support. Cash and deposits of 46.5B yen provide substantial capacity to fund dividends from existing liquidity, indicating near-term dividend sustainability despite elevated payout. No share buyback activity was disclosed in the available data. The dividend policy appears oriented toward maintaining or growing absolute dividend levels despite earnings volatility, with the payout ratio fluctuating based on net income outcomes including non-recurring items. Given the impact of extraordinary losses on current period net income, the elevated payout ratio may not reflect underlying earnings power, suggesting the dividend is supportable from operating cash generation even though accounting net income is suppressed by impairments.
Goodwill and intangible asset impairment risk remains elevated following the 4.9B yen write-down in Americas segment, with remaining goodwill of 5.1B yen and total intangible assets requiring ongoing assessment for additional value deterioration if business conditions weaken or acquisition synergies fail to materialize. The Americas segment operating margin remains thin at 2.0% even after impairment, suggesting structural profitability challenges that could necessitate further restructuring or asset write-downs if performance does not improve. Working capital management risk is substantial, with accounts receivable increasing 56% to 46.1B yen and collection days at 81 suggesting extended customer payment terms or collection difficulties. Days sales outstanding deterioration combined with inventory expansion to 24.9B yen consuming 74 days of COGS creates 7.1B yen of incremental working capital deployment that strains cash conversion if sales growth moderates or collection performance weakens. The combination of receivables at 26% of revenue and inventory at 12% of revenue represents 38% of sales tied up in working capital, elevated relative to efficient norms and creating vulnerability to demand shocks that could impair asset values. Tax burden risk is evidenced by the 41.1% effective tax rate substantially exceeding Japan's standard corporate rate, suggesting potential ongoing elevated tax costs from international operations, deferred tax adjustments, or limited tax loss utilization that will continue constraining net income conversion from operating profits.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates strong operational efficiency relative to manufacturing industry peers while maintaining comparable financial health metrics. Profitability positioning shows ROE of 8.6% exceeding the manufacturing industry median of 5.2% for 2025-Q3, indicating superior equity returns despite current period net income compression from extraordinary items. Operating margin of 10.4% surpasses industry median of 8.7%, reflecting solid core business profitability, though net profit margin of 4.6% falls below industry median of 6.4% due to the impact of impairment charges and elevated tax burden that reduced earnings conversion. Financial Health metrics align closely with industry standards, with equity ratio of 62.9% matching industry median of 63.8%, demonstrating comparable capital adequacy. Current ratio of 223.7% falls below industry median of 283% but remains strong, providing substantial short-term liquidity coverage. Financial leverage of 1.59x approximates industry median of 1.53x, indicating balanced balance sheet gearing. Efficiency metrics show exceptional performance, with asset turnover of 1.18x more than double the industry median of 0.58x, highlighting substantially superior asset utilization efficiency in generating revenue. Inventory turnover of 74 days significantly outperforms industry median of 109 days, demonstrating faster inventory conversion despite recent inventory expansion. Receivables turnover of 81 days aligns closely with industry median of 83 days, though the rapid increase bears monitoring. Revenue growth of 7.0% substantially exceeds industry median of 2.8%, positioning the company in the upper quartile of manufacturing sector growth rates and reflecting strong market demand. The combination of above-median growth, superior asset efficiency, and industry-comparable financial strength indicates a fundamentally sound operating model, with current period profitability compression driven by non-recurring factors rather than structural competitive disadvantage. (Industry: Manufacturing sector, N=100 companies, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Revenue momentum of 7.0% growth substantially exceeding manufacturing industry median of 2.8% demonstrates strong market positioning and demand capture, particularly in the core Japan segment generating 78% of consolidated sales with stable profitability, though this growth is accompanied by working capital expansion that requires monitoring for cash conversion efficiency. The divergence between operating profit decline of 6.4% and revenue growth of 7.0% reflects operating leverage deterioration from corporate overhead expansion of 27.9% that outpaced sales growth, indicating scale benefits are not flowing through to profitability and suggesting management focus on cost discipline is warranted to restore margin expansion. Asset quality concerns are evidenced by the 4.9B yen impairment charge reducing goodwill 54% to 5.1B yen, with the Americas segment write-down signaling prior acquisition value deterioration and raising questions about remaining intangible asset carrying values and potential for additional write-downs if performance does not improve, particularly as Americas operating margin remains marginal at 2.0% post-impairment. Balance sheet strength provides strategic flexibility, with minimal debt of 0.7B yen, equity ratio of 62.9% aligned with industry median, and cash position of 46.5B yen supporting dividend capacity and potential growth investments, though working capital absorption of approximately 16B yen from receivables and inventory expansion suggests cash generation efficiency has weakened and management attention to collection and inventory optimization would enhance cash flow quality.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.